Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > TY to the DA’s that sold at 5.5¢

<< Previous

Bullboard Posts

Next >>

Comment by WORKINMONTANAon Mar 02, 2021 8:50pm

393 Views

Post# 32701814

RE:TY to the DA’s that sold at 5.5¢

[url=https://kalyteran.co/index.php?/topic/648-news-report-says-2-of-3-covid-studies-for-us-based-biotech/]https://kalyteran.co/index.php?/topic/648-news-report-says-2-of-3-covid-studies-for-us-based-biotech/[/url]

WORKINMONTANA wrote: MUST READ

[url=https://kalyteran.co/index.php?/topic/648-news-report-says-2-of-3-covid-studies-for-us-based-biotech/]News Report Says 2 of 3 (2of3) COVID-19 Studies For USA Based Biotech[/url]

7NEWS Adelaide

July 27, 2020 at 9:48 AM Adelaide, SA, Australia

Volunteers wanted for paid clinical trials

South Australians are earning hundreds of dollars a day by taking part in clinical trials to find treatments for COVID.

The local company involved is looking for more volunteers saying it's been run off its feet.

More info: https://7news.link/2D73zle

#7NEWS